LMAT Lemaitre Vascular Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LMAT

Price (delayed)

$80.59

Market cap

$1.84B

P/E Ratio

27.79

Dividend/share

$0.95

EPS

$2.9

Enterprise value

$2.01B

?
Relative Growth: Rel. Growth: 95
Relative Strength: Rel. Strength: 25
Relative Valuation: Rel. Valuation: 44
Relative Profitability: Rel. Profitability: 91

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures ...

Highlights
LMAT's net income is up by 39% year-on-year and by 5% since the previous quarter
The EPS has grown by 38% YoY and by 5% from the previous quarter
The company's debt rose by 2.3% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.lemaitre.com
Peers: ANGO BSX EW BAX

Key stats

What are the main financial stats of LMAT

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
2.27%
1 week
-0.1%
1 month
-2.72%
1 year
-14.48%
YTD
-0.63%
QTD
-16.02%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$262.43M
Gross profit
$191.31M
Operating income
$77.32M
Net income
$65.67M
Gross margin
72.9%
Net margin
25%
The operating income has grown by 41% YoY and by 6% from the previous quarter
LMAT's net income is up by 39% year-on-year and by 5% since the previous quarter
The company's operating margin rose by 27% YoY and by 3.5% QoQ
The company's net margin rose by 24% YoY and by 2.9% QoQ

Price vs fundamentals

How does LMAT's price correlate with its fundamentals

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
LMAT P/E details
P/E
27.79
P/B
4.38
P/S
7.02
EV/EBIT
22.31
EV/EBITDA
19.98
EV/Sales
7.65
The EPS has grown by 38% YoY and by 5% from the previous quarter
The P/E is 36% less than the 5-year quarterly average of 43.6 and 21% less than the last 4 quarters average of 35.3
LMAT's price to book (P/B) is 17% lower than its last 4 quarters average of 5.3 and 11% lower than its 5-year quarterly average of 4.9
The equity has grown by 16% YoY and by 3.4% from the previous quarter
The P/S is 16% below the last 4 quarters average of 8.4 and 9% below the 5-year quarterly average of 7.7
Lemaitre Vascular's revenue has increased by 12% YoY and by 2.4% from the previous quarter

Efficiency

How efficient is Lemaitre Vascular business performance
The ROS has grown by 27% YoY and by 2.4% from the previous quarter
The ROE has grown by 20% YoY
Lemaitre Vascular's return on assets has increased by 16% YoY and by 2.9% QoQ
LMAT's ROIC is up by 10% year-on-year

Dividends

What is LMAT's dividend history
Dividend details
DPS
$0.95
Dividend yield
1.18%
Payout ratio
32.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lemaitre Vascular financials performed over time
The company's total assets is 191% higher than its total liabilities
LMAT's quick ratio is up by 19% YoY and by 14% QoQ
Lemaitre Vascular's current ratio has increased by 17% YoY and by 14% from the previous quarter
The company's debt is 55% lower than its equity
The equity has grown by 16% YoY and by 3.4% from the previous quarter
Lemaitre Vascular's debt to equity has decreased by 12% YoY and by 4.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.